John Volpone

Insider Reports History

Location
San Francisco, CA
Signature
/s/ David Kirske, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Volpone:

Company Role Class Num Shares Value Price $ Report Date Ownership
X4 Pharmaceuticals, Inc President Common Stock 289,881 $1,136,333 $3.92 14 Aug 2025 Direct
X4 Pharmaceuticals, Inc President Stock Option (right to buy) 2,329,154 29 Oct 2025 Direct

Insider Reports Filed by John Volpone

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XFOR X4 Pharmaceuticals, Inc 29 Oct 2025 1 $0 4 President 31 Oct 2025, 16:41
XFOR X4 Pharmaceuticals, Inc 12 Aug 2025 3 $0 4 President 14 Aug 2025, 20:31
XFOR X4 Pharmaceuticals, Inc 12 Aug 2025 0 $0 3 President 14 Aug 2025, 20:31